标题
Amino acid metabolism in hematologic malignancies and the era of targeted therapy
作者
关键词
-
出版物
BLOOD
Volume 134, Issue 13, Pages 1014-1023
出版商
American Society of Hematology
发表日期
2019-08-16
DOI
10.1182/blood.2019001034
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II
- (2019) Courtney L. Jones et al. BLOOD
- Targeting Glutamine Metabolism and Redox State for Leukemia Therapy
- (2019) Mark A. Gregory et al. CLINICAL CANCER RESEARCH
- Metabolic regulation of cell growth and proliferation
- (2019) Jiajun Zhu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Glutaminolysis is a metabolic dependency in FLT3ITDacute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition
- (2018) Paolo Gallipoli et al. BLOOD
- Glutaminase inhibition improves FLT3 inhibitor therapy for acute myeloid leukemia
- (2018) Mark A. Gregory et al. EXPERIMENTAL HEMATOLOGY
- Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells
- (2018) Courtney L. Jones et al. CANCER CELL
- Targeting the arginine metabolic brake enhances immunotherapy for leukaemia
- (2018) Francis Mussai et al. INTERNATIONAL JOURNAL OF CANCER
- Integrated Stress Response Activity Marks Stem Cells in Normal Hematopoiesis and Leukemia
- (2018) Peter van Galen et al. Cell Reports
- Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers
- (2017) Emma Beddowes et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug-induced amino acid deprivation as strategy for cancer therapy
- (2017) Marcus Kwong Lam Fung et al. Journal of Hematology & Oncology
- Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia
- (2017) Ayuna Hattori et al. NATURE
- BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation
- (2017) Simon Raffel et al. NATURE
- Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment
- (2017) Susanne M. Steggerda et al. Journal for ImmunoTherapy of Cancer
- Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche
- (2016) Haobin Ye et al. Cell Stem Cell
- Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections
- (2016) H. S. Fernandes et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
- (2016) Shira L Cramer et al. NATURE MEDICINE
- Arginine dependence of tumor cells: targeting a chink in cancer’s armor
- (2016) M D Patil et al. ONCOGENE
- Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation
- (2016) Y. Taya et al. SCIENCE
- A metabolic synthetic lethal strategy with arginine deprivation and chloroquine leads to cell death in ASS1-deficient sarcomas
- (2016) Gregory R Bean et al. Cell Death & Disease
- Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor
- (2016) Abigail S. Krall et al. Nature Communications
- Inhibiting glutaminase in acute myeloid leukemia: metabolic dependency of selected AML subtypes
- (2016) Polina Matre et al. Oncotarget
- Hypoxia and metabolic adaptation of cancer cells
- (2016) K L Eales et al. Oncogenesis
- Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
- (2015) F. Mussai et al. BLOOD
- Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition
- (2015) N. Jacque et al. BLOOD
- Arginine deprivation using pegylated arginine deiminase has activity against primary acute myeloid leukemia cells in vivo
- (2015) F. Miraki-Moud et al. BLOOD
- Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
- (2015) Isaac S. Harris et al. CANCER CELL
- PEGylation and pharmacological characterization of a potential anti-tumor drug, an engineered arginine deiminase originated from Pseudomonas plecoglossicida
- (2015) Long Zhang et al. CANCER LETTERS
- Glutaminase activity determines cytotoxicity of l-asparaginases on most leukemia cell lines
- (2015) Jean Hugues Parmentier et al. LEUKEMIA RESEARCH
- Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines
- (2015) Wei-Wen Chien et al. Scientific Reports
- The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells
- (2014) W. K. Chan et al. BLOOD
- Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling
- (2014) Jiangbo Liu et al. BMC CANCER
- Myelodysplastic Cells in Patients Reprogram Mesenchymal Stromal Cells to Establish a Transplantable Stem Cell Niche Disease Unit
- (2014) Hind Medyouf et al. Cell Stem Cell
- Asparagine Depletion Potentiates the Cytotoxic Effect of Chemotherapy against Brain Tumors
- (2014) Eduard H. Panosyan et al. MOLECULAR CANCER RESEARCH
- Asparagine Plays a Critical Role in Regulating Cellular Adaptation to Glutamine Depletion
- (2014) Ji Zhang et al. MOLECULAR CELL
- Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironment
- (2013) F. Mussai et al. BLOOD
- Asparaginase unveils glutamine-addicted AML
- (2013) I. Samudio et al. BLOOD
- Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
- (2013) Luika A. Timmerman et al. CANCER CELL
- Adipocytes Cause Leukemia Cell Resistance to L-Asparaginase via Release of Glutamine
- (2013) E. A. Ehsanipour et al. CANCER RESEARCH
- Loss of p53 and altered miR15-a/16-1→MCL-1 pathway in CLL: insights from TCL1-Tg:p53 −/− mouse model and primary human leukemia cells
- (2013) J Liu et al. LEUKEMIA
- Nitric oxide and cancer: a review
- (2013) Sheetal Korde Choudhari et al. World Journal of Surgical Oncology
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells
- (2012) W.-B. Tsai et al. CANCER RESEARCH
- Erwinia asparaginase in pediatric acute lymphoblastic leukemia
- (2012) Wanda Salzer et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma
- (2012) Patrick A. Ott et al. INVESTIGATIONAL NEW DRUGS
- Withdrawal of Essential Amino Acids Increases Autophagy by a Pathway Involving Ca2+/Calmodulin-dependent Kinase Kinase-β (CaMKK-β)
- (2012) Ghita Ghislat et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
- (2012) Wan Zhang et al. NATURE CELL BIOLOGY
- Cancer Cell Metabolism: One Hallmark, Many Faces
- (2012) Jason R. Cantor et al. Cancer Discovery
- Polyethylene Glycol-conjugated L-asparaginase Versus Native L-asparaginase in Combination With Standard Agents for Children With Acute Lymphoblastic Leukemia in Second Bone Marrow Relapse
- (2011) Joanne Kurtzberg et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Hypoxia Triggers AMPK Activation through Reactive Oxygen Species-Mediated Activation of Calcium Release-Activated Calcium Channels
- (2011) P. T. Mungai et al. MOLECULAR AND CELLULAR BIOLOGY
- Targeting cancer metabolism: a therapeutic window opens
- (2011) Matthew G. Vander Heiden NATURE REVIEWS DRUG DISCOVERY
- Purification and characterization of glutaminase-free l-asparaginase from Pectobacterium carotovorum MTCC 1428
- (2010) Sanjay Kumar et al. BIORESOURCE TECHNOLOGY
- Rational engineering of L-asparaginase reveals importance of dual activity for cancer cell toxicity
- (2010) M. N. Offman et al. BLOOD
- Pegylated arginase I: a potential therapeutic approach in T-ALL
- (2010) C. P. Hernandez et al. BLOOD
- A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients
- (2010) T-S Yang et al. BRITISH JOURNAL OF CANCER
- Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma
- (2010) Evan S. Glazer et al. JOURNAL OF CLINICAL ONCOLOGY
- Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells
- (2010) Kwong-Lam Fung et al. LEUKEMIA & LYMPHOMA
- Mammalian polyamine metabolism and function
- (2009) Anthony E. Pegg IUBMB LIFE
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Arginine Deprivation as a Targeted Therapy for Cancer
- (2008) L. Feun et al. CURRENT PHARMACEUTICAL DESIGN
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started